LGND

Ligand Pharma

• Reuters·5d ago

  Ligand director John W. Kozarich disposes of shares worth $0.1 million

• Reuters·5d ago

  Ligand CLO Andrew Reardon disposes of LGND shares worth $0.99 million

• TipRanks·04/01 02:02

  Major Insider Move at Ligand Pharma Sparks Investor Buzz

• Reuters·03/31 21:53

  Ligand director John LaMattina disposes of common shares worth $0.43 million

• NASDAQ·03/27 23:40

  Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know

• TipRanks·03/26 15:30

  Analysts Are Bullish on Top Healthcare Stocks: Lucid Diagnostics (LUCD), Ligand Pharma (LGND)

• Reuters·03/26 11:03

  Ligand Pharmaceuticals appoints Peter Renehan and Lee Brown as VPs of Investments and Business Development; Lauren Hay moves to VP of Portfolio Strategy and Investments

• TipRanks·03/26 02:08

  Insider Shake-Up at Ligand Pharma Sparks Fresh Market Buzz

• Reuters·03/25 15:14

  Ligand Pharmaceuticals; Director Stephen L. Sabba drops 1,000 common shares worth $207,873

• Dow Jones·03/24 15:23

  Ligand Pharmaceuticals Price Target Raised to $276.00/Share From $270.00 by Citigroup

• Dow Jones·03/24 15:23

  Ligand Pharmaceuticals Is Maintained at Buy by Citigroup

• Benzinga·03/24 15:14

  Citigroup Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $276

• TipRanks·03/24 10:05

  Citi ups Ligand target, opens ‘upside 90-day catalyst watch’

• Reuters·03/24 10:03

  LIGAND PHARMACEUTICALS INC <LGND.O>: CITIGROUP RAISES TARGET PRICE TO $276 FROM $270

• Reuters·03/24 07:39

  U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco